Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JJ6T
|
||||
| Former ID |
DNC009159
|
||||
| Drug Name |
N6-((+/-)-endo-norborn-2-yl)adenosine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530035] | ||
| Formula |
C17H23N5O4
|
||||
| Canonical SMILES |
C1CC2CC1CC2NC3=NC=NC4=C3N=CN4C5C(C(C(O5)CO)O)O
|
||||
| InChI |
1S/C17H23N5O4/c23-5-11-13(24)14(25)17(26-11)22-7-20-12-15(18-6-19-16(12)22)21-10-4-8-1-2-9(10)3-8/h6-11,13-14,17,23-25H,1-5H2,(H,18,19,21)/t8?,9?,10?,11-,13-,14-,17-/m1/s1
|
||||
| InChIKey |
YKPCEENRZZBDMC-STHLEMNDSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530035] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [530035] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [530035] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [530035] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.